Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Oguma

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|July 1, 1996
[A heavy drinker case of HCV-Ab positive porphyria cutanea tarda, followed by primary hepatocellular carcinoma]T Oguma, N Tsukada, K Miyamoto, et al.
The Keio Journal of Medicine|April 17, 1999
An HIV autopsy--characterization of zidovudine-resistant subtype E HIV-1 from autopsy tissue suggests the route of infection and an alternative protocol of therapyM Negishi, A Umezawa, M Katayama, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 29, 2013
Smoking attenuates the age-related decrease in IgE levels and maintains eosinophilic inflammationT Nagasaki, H Matsumoto, H Nakaji, et al.
Bioorganic & Medicinal Chemistry|July 31, 1999
Novel vasopressin V2 receptor-selective antagonists, pyrrolo[2,1-a]quinoxaline and pyrrolo[2,1-c][1,4]benzodiazepine derivativesY Ohtake, A Naito, H Hasegawa, et al.
American Journal of Respiratory and Critical Care Medicine|April 14, 2000
Longitudinal follow-up study of smoking-induced lung density changes by high-resolution computed tomographyK Soejima, K Yamaguchi, E Kohda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Phase I and pharmacokinetic study of TZT-1027, a novel synthetic dolastatin 10 derivative, administered as a 1-hour intravenous infusion every 3 weeks in patients with advanced refractory cancerP Schöffski, B Thate, G Beutel, et al.
Journal of Investigational Allergology & Clinical Immunology|June 21, 2008
Sputum levels of transforming growth factor-beta1 in asthma: relation to clinical and computed tomography findingsM Yamaguchi, A Niimi, H Matsumoto, et al.
The Japanese Journal of Antibiotics|October 17, 1998
[The 3rd Japanese-United States Vancomycin Forum]K Shimada, A Saito, K Yamaguchi, et al.
Biological & Pharmaceutical Bulletin|March 8, 2000
Pharmacological profile of VP-343, a novel selective vasopressin V2 receptor antagonist, in ratsA Naito, Y Ohtake, H Hasegaw, et al.
Journal of Investigational Allergology & Clinical Immunology|April 6, 2011
Long-term changes in airway-wall thickness on computed tomography in asthmatic patientsH Matsumoto, A Niimi, M Takemura, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|July 1, 1996
[A heavy drinker case of HCV-Ab positive porphyria cutanea tarda, followed by primary hepatocellular carcinoma]T Oguma, N Tsukada, K Miyamoto, et al.
The Keio Journal of Medicine|April 17, 1999
An HIV autopsy--characterization of zidovudine-resistant subtype E HIV-1 from autopsy tissue suggests the route of infection and an alternative protocol of therapyM Negishi, A Umezawa, M Katayama, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 29, 2013
Smoking attenuates the age-related decrease in IgE levels and maintains eosinophilic inflammationT Nagasaki, H Matsumoto, H Nakaji, et al.
Bioorganic & Medicinal Chemistry|July 31, 1999
Novel vasopressin V2 receptor-selective antagonists, pyrrolo[2,1-a]quinoxaline and pyrrolo[2,1-c][1,4]benzodiazepine derivativesY Ohtake, A Naito, H Hasegawa, et al.
American Journal of Respiratory and Critical Care Medicine|April 14, 2000
Longitudinal follow-up study of smoking-induced lung density changes by high-resolution computed tomographyK Soejima, K Yamaguchi, E Kohda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Phase I and pharmacokinetic study of TZT-1027, a novel synthetic dolastatin 10 derivative, administered as a 1-hour intravenous infusion every 3 weeks in patients with advanced refractory cancerP Schöffski, B Thate, G Beutel, et al.
Journal of Investigational Allergology & Clinical Immunology|June 21, 2008
Sputum levels of transforming growth factor-beta1 in asthma: relation to clinical and computed tomography findingsM Yamaguchi, A Niimi, H Matsumoto, et al.
The Japanese Journal of Antibiotics|October 17, 1998
[The 3rd Japanese-United States Vancomycin Forum]K Shimada, A Saito, K Yamaguchi, et al.
Biological & Pharmaceutical Bulletin|March 8, 2000
Pharmacological profile of VP-343, a novel selective vasopressin V2 receptor antagonist, in ratsA Naito, Y Ohtake, H Hasegaw, et al.
Journal of Investigational Allergology & Clinical Immunology|April 6, 2011
Long-term changes in airway-wall thickness on computed tomography in asthmatic patientsH Matsumoto, A Niimi, M Takemura, et al.
Pageof 10